Click image to view original image
Product Details
Basic Info.
Model NO.:112809-51-5
Name:Letrozole Femara
CAS No:112809-51-5
Purity:99%
Molecular Formula:C17h11n5
Molecular Weight:285.3
Shipping:FedEx, DHL, EMS, TNT, HK EMS, HK Post
Export Markets:Global
Payment:Western unio, Money Gram, Paypal
Additional Info.
Packing:Aluminum Foil Bag
Standard:ISO9001
Origin:Hubei, China
Production Capacity:500g/Month
Product Description
Our Adwantage:
1,Letrozole Femara has a high quality with competitive price:
1)Standard:ISO9001
2)All Purity≥99%
3)We are manufacturer and can provide high quality products with factory price.
2,Fast and safe delivery
1)Parcel can be sent out in 24 hours after payment.Tracking number available
2)Secure and discreet shipment.Various transportation methods for your choice.
3)Customs pass rate ≥99%
4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe, and we have stock in there for transferring.
3,We have clients throughout the world.
1)Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.
2)Market feedback and goods feedback will be appreciated, meeting customer's requirement is our responsibility.
3) High quality,competitive price,fast delivery ,first-class service gain the trust and praise from the customers.
4.Our company has a strict QA&QC system and all of products are in line with the USP standard as well as enterprise internal control standard
Product Description
Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Letrozole is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.
Skype:silvialiu
Email Address:exo@yccreate.com
Whats App:18872220709
Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Letrozole is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.
Skype:silvialiu
Email Address:exo@yccreate.com
Whats App:18872220709
